Frequency ranges from daily to weekly depending on the specific peptide, and dosing is customized based on your response, tolerance, and treatment goals
Treatment is guided by the same Utah-based MD, with personalized dosing, side-effect support, and long-term weight management focused on safe, sustainable weight loss
Semaglutide requires titration
About 8 in 10 people receive their prescription in person from a primary care provider or specialist, compared with 10% who use telehealth
Glucagon-like peptide-1 receptor agonist (GLP-1RA) and sodium-glucose cotransporter 2 inhibitor (SGLT2i) are currently recommended as first-line hypoglycaemic agents for patients with diabetes with established cardiovascular disease or multiple cardiovascular and renal risks [10]
Most people who use these drugs will need a higher dose to maintain weight loss